Ario was engaged in developing new therapeutics for the treatment of pain, respiratory conditions and type II diabetes in cooperation with pharmaceutical partners.
The company’s assets have now either been acquired or licensed to pharma companies.
Copyright © 2024 Seroba. All rights reserved.
Legal | Privacy | Sustainability